Ronald Lorijn, NeuExcell CEO

NeuEx­cell heads east, land­ing sub­ur­ban Philly head­quar­ters

Penn­syl­va­nia’s al­ready well-es­tab­lished biotech scene got word of a boost last week with sev­er­al an­nounce­ments, in­clud­ing the build­ing of a mas­sive life sci­ences man­u­fac­tur­ing cen­ter in Pitts­burgh thanks to some fund­ing from an area non­prof­it and a lo­cal uni­ver­si­ty. But those jawns in Philadel­phia aren’t let­ting go of its stran­gle­hold on the state eas­i­ly.

NeuEx­cell Ther­a­peu­tics, a pre­clin­i­cal gene ther­a­py biotech that fo­cus­es on neu­rode­gen­er­a­tive dis­eases, an­nounced that it signed a deal with The Dis­cov­ery Labs in King of Prus­sia, about 25 miles north­west of down­town Philly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.